FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely obstetrics and gynecology, and can be used to determine the degree of cervical dysplasia. In patients during a clinical examination using a video colposcope, a video examination of the vagina and uterine cervix is recorded in Full HD resolution. A snapshot is obtained that displays the anatomical structure, the affected areas of the surface of the uterine cervix and the outer portion of the cervical canal. The image is processed using ImageJ software. With the help of software tools, the amount of affected tissue per unit area of the entire surface of the uterine cervix is calculated with the introduction of diagnostic intensity indices of the affected area, assessing the severity of cervical dysplasia, according to the proposed formula: where IndGV is a uniform intensity index; IndInt is the intensity index of the affected area; dGV is the range of change in the gray color of the affected area. where Area is the total surface area of the uterine cervix, % area is the percentage of the affected area on the surface of the uterine cervix. CIN1 corresponds to IndGV = 4.75. CIN2 corresponds to IndGV = 6.99. CIN3 corresponds to IndGV = 8.46. In this case, CIN I is a mild degree of dysplasia, CIN 2 is a moderate degree of dysplasia, CIN 3 is a severe degree of dysplasia.
EFFECT: method provides determination of the degree of dysplasia due to a quantitative indicator of the intensity of the affected area.
1 cl, 10 dwg, 5 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR ASSESSING DEGREE OF MALIGNANCY OF INTRAEPITHELIAL INVOLVEMENT OF SQUAMOUS EPITHELIUM OF UTERUS | 2023 |
|
RU2818148C1 |
METHOD OF CHOOSING TACTICS OF MANAGING PATIENTS WITH CERVICAL NEOPLASIA | 2011 |
|
RU2472424C1 |
METHOD FOR PREDICTING COURSE AND SEVERITY OF HUMAN PAPILLOMAVIRUS INFECTION OF CERVIX | 2022 |
|
RU2804230C1 |
METHOD OF TREATING BACKGROUND AND PRECANCEROUS CERVICAL DISEASES | 2023 |
|
RU2813949C1 |
METHOD FOR THE TREATMENT OF PRECANCER AND THE INITIAL FORM OF CERVICAL CANCER | 2022 |
|
RU2796184C1 |
METHOD FOR DETERMINING MANAGEMENT OF PATIENTS WITH MODERATE DYSPLASTIC CHANGES IN CERVIX UTERI | 2019 |
|
RU2704798C1 |
METHOD OF PERSONALIZED TREATMENT OF HPV-ASSOCIATED RECURRENT CHRONIC CERVICITIS BASED ON IMMUNOGENETIC CRITERIA | 2017 |
|
RU2712016C2 |
METHOD OF COMBINED THERAPY OF CERVICAL DYSPLASIA ASSOCIATED WITH HUMAN PAPILLOMA VIRUSES | 2019 |
|
RU2701525C1 |
METHOD FOR COMBINED TREATMENT OF PATIENTS WITH HPV-ASSOCIATED CERVICAL SQUAMOUS INTRAEPITHELIAL LESIONS CIN II-III | 2023 |
|
RU2819504C1 |
METHOD FOR PREDICTION OF PROGRESSION OF LOW-GRADE CERVICAL SQUAMOUS INTRAEPITHELIAL LESION WITH UNDERLYING HUMAN PAPILLOMAVIRUS INFECTION | 2021 |
|
RU2766719C1 |
Authors
Dates
2021-10-28—Published
2020-06-25—Filed